Avance Clinical悉尼办公室正式启动 Mar 02, 2022 15:00 HKT | |
|
Avance Clinical悉尼辦公室正式啟動 Mar 02, 2022 15:00 HKT | |
|
Therapeutic Goods Administration of Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years) Feb 17, 2022 10:45 HKT | |
|
Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries Feb 16, 2022 07:00 HKT | |
|
Novotech Recognized as Top 10 CRO in CenterWatch Global Site Relationship Benchmarking Report Feb 09, 2022 15:00 HKT | |
|
Avance Clinical在2022年生物技术展上宣布为美国扩张进行重大私募股权投资 Jan 19, 2022 07:00 HKT | |
|
Avance Clinical在2022年生物技術展上宣佈為美國擴張進行重大私募股權投資 Jan 19, 2022 07:00 HKT | |
|
아방스 클리니컬 바이오테크 쇼케이스 2022에서 미국에서의 확장을 위한 대규모적인 PE 투자를 발표 Jan 19, 2022 07:00 HKT | |
|
Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022 Jan 18, 2022 13:00 HKT | |
|
冠科美博 (Apollomics Inc.) 将于 2022 年 1 月 26-27 日(周三、周四)举办线上投资者活动 Jan 12, 2022 09:27 HKT | |
|
冠科美博 (Apollomics Inc.) 將於 2022 年 1 月 26-27 日(週三、週四)舉辦線上投資者活動 Jan 12, 2022 09:26 HKT | |
|
Apollomics Inc. to Host Virtual Investor Events on Wednesday, January 26, 2022 and Thursday, January 27, 2022 Jan 12, 2022 09:25 HKT | |
|
B-cell lymphoma clinical trials now open on the TrialWire Platform Jan 05, 2022 17:10 HKT | |
|
Autism clinical trials now open on the TrialWire Platform Jan 05, 2022 17:00 HKT | |
|
冠科美博(Apollomics)首席执行官余国良博士当选为百华协会 (BayHelix Group) 董事会主席 Jan 04, 2022 10:12 HKT | |
|
冠科美博(Apollomics)首席執行官余國良博士當選為百華協會 (BayHelix Group) 董事會主席 Jan 04, 2022 10:11 HKT | |
|
Apollomics Inc. Announces CEO Guo-Liang Yu, PhD Appointed as Chairman of the Board for the BayHelix Group Jan 04, 2022 10:10 HKT | |
|
冠科美博(Apollomics)Uproleselan 注射液(APL-106)用于治疗复发或难治性急性髓系白血病的中国 III 期临床试验第一例受试者成功入组 Nov 22, 2021 10:42 HKT | |
|
冠科美博(Apollomics)Uproleselan 注射液(APL-106)用於治療復發或難治性急性髓系白血病的中國 III 期臨床試驗第一例受試者成功入組 Nov 22, 2021 10:41 HKT | |
|
Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial with APL-106 (Uproleselan Injection) in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia Nov 22, 2021 10:40 HKT | |
|